Free Cash Flow Chart

View Free Cash Flow for MGTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 10.06M
March 31, 2026 3.745M
December 31, 2025 -50.60M
September 30, 2025 -121.04M
June 30, 2025 -133.96M
March 31, 2025 -109.57M
December 31, 2024 -109.45M
September 30, 2024 -102.53M
June 30, 2024 -104.76M
March 31, 2024 -117.96M
December 31, 2023 -125.54M
September 30, 2023
June 30, 2023
March 31, 2023
September 30, 2022 -98.84M
Date Value
June 30, 2022 -97.19M
March 31, 2022 -82.22M
December 31, 2021 -65.75M
September 30, 2021 -100.00M
June 30, 2021 -99.89M
March 31, 2021 -88.85M
December 31, 2020 -100.99M
September 30, 2020 -87.91M
June 30, 2020 -79.37M
March 31, 2020 -86.41M
December 31, 2019 11.06M
September 30, 2019 17.43M
June 30, 2019 25.81M
March 31, 2019 29.51M
December 31, 2018 -70.15M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Xencor, Inc. -208.28M
UroGen Pharma Ltd. -170.67M
Ironwood Pharmaceuticals, Inc. 185.55M
Viking Therapeutics, Inc. -418.44M
IDEAYA Biosciences, Inc. -113.87M